Product information

Current status:

Cancelled Post Market

Current status date:

2004-08-05

Original market date: ^{See footnote 1}

1993-12-31

Product name:

NARCAN INJECTION 0.02MG/ML

DIN:

01913948 Electronic product monograph is not available

Company:

BRISTOL-MYERS SQUIBB CANADA
2344 Boul. Alfred-Nobel, Suite 300
St-Laurent
Quebec
Canada H4S 0A4

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intramuscular ,  Intravenous ,  Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:10.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

V03AB15 NALOXONE

Active ingredient group (AIG) number:^{See footnote5}

0108981003